CompletedPhase 3NCT00290823

Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

Studying Cysticercosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Theodore E. Nash, MD
Gastrointestinal Parasites Section, Laboratory of Parasitic Diseases, NIAID
Intervention: Albendazole(drug)
Enrollment: 110 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2006 – 2011

Study locations (1)

Instituto Especializado en Ciencias Neurologicas, Lima, Peru

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00290823 on ClinicalTrials.gov

Other trials for Cysticercosis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001205
Natural History of Treated Neurocysticercosis and Long-Term Outcomes
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Cysticercosis →

← Back to all trials